In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Tanker Pursued by U.S. Claims Russian Protection, Officials Say The tanker was headed to Venezuela to collect oil, putting it in the cross-hairs of President Trump’s pressure campaign on Nicolás ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback